Back to Search Start Over

Dupilumab Reduced Oral Corticosteroid Use in Patients with OCS-Dependent Severe Asthma Consistently Across Baseline Disease Characteristics in the Phase 3 LIBERTY ASTHMA VENTURE Study

Authors :
Yamo Deniz
N. Pandit-Abid
Mario Castro
N. Daizadeh
Benjamin Ortiz
P. Rowe
Nicola A. Hanania
Source :
B32. ASTHMA OUTCOMES.
Publication Year :
2020
Publisher :
American Thoracic Society, 2020.

Subjects

Subjects :
medicine.medical_specialty
business.industry
Severe asthma
Internal medicine
Medicine
Disease characteristics
Corticosteroid use
In patient
business
Baseline (configuration management)
medicine.disease
Dupilumab
Asthma

Details

Database :
OpenAIRE
Journal :
B32. ASTHMA OUTCOMES
Accession number :
edsair.doi...........4cb5b591528e79388c1e685afcca1536
Full Text :
https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3030
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details